Sanofi Half-Year Financial Report for 2025 Available
Sanofi announced on July 31, 2025, that its half-year financial report for the period ending June 30, 2025, is now available. The report has been filed with French and U.S. regulatory authorities.
Paris – Sanofi has made its half-year financial report for 2025 available, announcing on July 31, 2025, that the document has been filed. The pharmaceutical company submitted the report to the French financial markets regulator, Autorité des marchés financiers (AMF), and the U.S. Securities and Exchange Commission (SEC) via Form 6-K.
The report covers the financial performance for the first six months of the year, concluding on June 30, 2025. It is accessible for download on the company's corporate website, Sanofi.com, within the Investors section under the heading "Regulated Information."
This release follows standard procedure for Sanofi's financial disclosures, providing stakeholders with an update on the company's financial standing. The availability of such reports is crucial for market transparency and investor analysis.
Sanofi is a global biopharmaceutical company focused on research-driven innovation to improve people's lives through its development of medicines and vaccines.